CN Patent

CN102256618A — 胰岛素和glp-1激动剂的组合

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2011-11-23 · 14y expired

What this patent protects

本发明涉及包含至少一种胰岛素和至少一种GLP-1受体激动剂的药物。

USPTO Abstract

本发明涉及包含至少一种胰岛素和至少一种GLP-1受体激动剂的药物。

Drugs covered by this patent

Patent Metadata

Patent number: CN102256618A
Jurisdiction: CN
Classification: —
Expires: 2011-11-23
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi Aventis Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.